03:52 AM EST, 12/05/2024 (MT Newswires) -- Janux Therapeutics ( JANX ) said late Wednesday it priced a public offering of 5.3 million shares at $63 per share, along with pre-funded warrants for 238,095 shares at $62.999 per warrant.

The offering is expected to raise approximately $350 million in gross proceeds. The underwriters have a 30-day option to purchase up to 833,333 additional shares.

Proceeds from the offering, set to close on Friday, will support the clinical development of the company's product pipeline and general corporate purposes, Janux said.